Marc Stapley Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 2 hours ago
Marc Stapley has an estimated net worth of at least $12.6 million*, as of Dec. 11, 2024. They own 312,935 shares of VCYT stock. They have sold 35,000 shares of VCYT stock since 2021, for an estimated $-980,094.
Marc Stapley $VCYT SEC Form 4 Insider Trading
Marc Stapley has filed a total of 1 insider trades in $VCYT since 2021. Their most recent trade was a purchase of 60,000 shares, made on Jun 10, 2022. Their largest trade was a purchase of 60,000 shares, made on Jun 10, 2022. We estimate that they now own 312,935 shares of $VCYT, worth an estimated $13.6 million.
Insider Trading at $VCYT
There have been a total of 94 insider trades reported at $VCYT since 2021, with 62,000 shares purchased and 786,335 shares sold. The most active insider traders in $VCYT stock have been Giulia C Kennedy, Bonnie H Anderson, and John Leite. The most recent trade was a sale of 3,934 shares reported by Phillip G. Febbo (Chief Scientific & Med Officer), made on Dec 04, 2024.
History of Insider Stock Trades by Marc Stapley
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
GKOS
|
Sale | 600 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 1,110 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 3,959 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 581 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 2,050 | May 15, 2024 | May 16, 2024, 7:45 p.m. |
|
GKOS
|
Sale | 2,200 | May 15, 2024 | May 16, 2024, 7:45 p.m. |
|
GKOS
|
Sale | 2,000 | May 15, 2024 | May 16, 2024, 7:45 p.m. |
|
GKOS
|
Sale | 2,437 | Feb 29, 2024 | March 4, 2024, 9:09 p.m. |
|
GKOS
|
Sale | 1,500 | Feb 29, 2024 | March 4, 2024, 9:09 p.m. |
|
GKOS
|
Sale | 2,313 | Feb 29, 2024 | March 4, 2024, 9:09 p.m. |
|
GKOS
|
Sale | 9,206 | Dec 14, 2023 | Dec. 18, 2023, 9:40 p.m. |
|
GKOS
|
Sale | 7,044 | Dec 14, 2023 | Dec. 18, 2023, 9:40 p.m. |
VCYT
|
Purchase | 60,000 | Jun 10, 2022 | June 13, 2022, 8:19 a.m. |
$VCYT Executives and Stock Owners with Insider Trades
-
Giulia C Kennedy, Chief Scientific & Med Officer
-
Bonnie H Anderson, Executive Chairwoman
-
John Leite, Chief Commercial Officer-CLIA
-
Jonathan Wygant, VP, Chief Accounting Officer
-
Rebecca Chambers, Chief Financial Officer
-
Annie Mcguire, SVP, General Counsel
-
Marc Stapley, Chief Executive Officer
-
Phillip G. Febbo, Chief Scientific & Med Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.